Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...